ABT-199, a BH3 mimetic that specifically targets Bcl-2, enhances the antitumor activity of chemotherapy, bortezomib and JQ1 in "double hit" lymphoma cells (Q38942453)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ABT-199, a BH3 mimetic that specifically targets Bcl-2, enhances the antitumor activity of chemotherapy, bortezomib and JQ1 in "double hit" lymphoma cells |
scientific article |
Statements
1 reference
ABT-199, a BH3 mimetic that specifically targets Bcl-2, enhances the antitumor activity of chemotherapy, bortezomib and JQ1 in "double hit" lymphoma cells (English)
1 reference
Nadine Johnson-Farley
1 reference
Jonny Veliz
1 reference
S Bhagavathi
1 reference
Joseph R Bertino
1 reference
28 January 2015
1 reference
1 reference
56
1 reference
7
1 reference
2146-2152
1 reference
Identifiers
1 reference
1 reference